Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Producing Natural Killer Immune Cells from Induced Pluripotent Stem Cells to Treat Cancer with Daniel Teper Cytovia Therapeutics TRANSCRIPT

Download PDF

May 31, 2022

Daniel Teper is the CEO and Founder of Cytovia Therapeutics and talks about using natural killer, NK, cells as an alternative to T-cells in immuno-oncology. He shares insights about the development of induced pluripotent stem cells, IPSC-derived NK cells, iNK cells, used by themselves or using their Flex-NK...

Producing Natural Killer Immune Cells from Induced Pluripotent Stem Cells to Treat Cancer with Daniel Teper Cytovia Therapeutics

May 31, 2022

Radiopharmaceutical Technology Creates Novel Radioantibodies to Treat Prostate Cancer with Dr. Phil Kantoff and Alex Brown Convergent Therapeutics TRANSCRIPT

Download PDF

May 30, 2022

Dr. Phil Kantoff is the CEO and Co-Founder and Alex Brown is the COO of Convergent Therapeutics which is developing the next generation of targeted therapies to treat cancer. Drawing on insights from developments in radiopharmaceuticals, Convergent focuses on radioantibodies that are radioisotopes attached to antibodies...

Radiopharmaceutical Technology Creates Novel Radioantibodies to Treat Prostate Cancer with Dr. Phil Kantoff and Alex Brown Convergent Therapeutics

May 30, 2022

Developing Lung Diagnostic Tests for COVID and Assessing Lung Transplant Donors with Dr. Eric Brouwer SQI Diagnostics TRANSCRIPT

Download PDF

May 26, 2022

Dr. Eric Brouwer is the Chief Scientific Officer for SQI Diagnostics, which believes that lung health is human health. Their focus is on the lung and ranges from COVID PCR, antigen, and antibody tests, across the spectrum to assessing lung transplant donors. With demand going up for lung transplants and new protocols...